Armand Krikorian1, Sapna Shah, Jay Wasman. 1. Division of Clinical and Molecular Endocrinology, University Hospitals Case Medical Center, Cleveland, Ohio 44106, USA. armand.krikorian@uhhospitals.org
Abstract
OBJECTIVE: To describe parathyroid hormone-related protein (PTHrP) as a mediator of hypercalcemia in sarcoidosis. METHODS: We present a detailed case report including history, physical, laboratory testing, pathology findings, and follow-up data over 2 years. We also propose a possible mechanism for PTHrP-mediated hypercalcemia in sarcoidosis. RESULTS: A 56-year-old man presented with abdominal pain, fatigue, and excess thirst. Routine laboratory testing demonstrated severe hypercalcemia. The patient was admitted for treatment and work-up. Inpatient work-up was significant for suppressed parathyroid hormone, low 25-hydroxyvitamin D, normal 1,25-dihydroxyvitamin D, and elevated PTHrP. The patient was treated for hypercalcemia and discharged for follow-up. Malignancy screening included computed tomography of the chest, which revealed parenchymal nodules and diffuse lymphadenopathy. Biopsy revealed nonnecrotizing granulomatous inflammation with positive PTHrP staining by immunohistochemistry. After treatment with intravenous hydration and glucocorticoids, the hypercalcemia resolved and on subsequent follow-up, PTHrP levels had normalized to 0.5 pmol/L. CONCLUSION: PTHrP may be a possible mediator of hypercalcemia in sarcoidosis. The differential diagnosis of PTHrP-induced hypercalcemia should include sarcoidosis, and further research is needed to establish the incidence and source of PTHrP in sarcoidosis.
OBJECTIVE: To describe parathyroid hormone-related protein (PTHrP) as a mediator of hypercalcemia in sarcoidosis. METHODS: We present a detailed case report including history, physical, laboratory testing, pathology findings, and follow-up data over 2 years. We also propose a possible mechanism for PTHrP-mediated hypercalcemia in sarcoidosis. RESULTS: A 56-year-old man presented with abdominal pain, fatigue, and excess thirst. Routine laboratory testing demonstrated severe hypercalcemia. The patient was admitted for treatment and work-up. Inpatient work-up was significant for suppressed parathyroid hormone, low 25-hydroxyvitamin D, normal 1,25-dihydroxyvitamin D, and elevated PTHrP. The patient was treated for hypercalcemia and discharged for follow-up. Malignancy screening included computed tomography of the chest, which revealed parenchymal nodules and diffuse lymphadenopathy. Biopsy revealed nonnecrotizing granulomatous inflammation with positive PTHrP staining by immunohistochemistry. After treatment with intravenous hydration and glucocorticoids, the hypercalcemia resolved and on subsequent follow-up, PTHrP levels had normalized to 0.5 pmol/L. CONCLUSION:PTHrP may be a possible mediator of hypercalcemia in sarcoidosis. The differential diagnosis of PTHrP-induced hypercalcemia should include sarcoidosis, and further research is needed to establish the incidence and source of PTHrP in sarcoidosis.
Authors: Pietro Giorgio Calò; Giuseppe Pisano; Alberto Tatti; Giulia Loi; Silvia Furcas; Angelo Nicolosi Journal: Clin Med Insights Case Rep Date: 2013-10-16
Authors: Łukasz Gwadera; Adam Jerzy Białas; Mikołaj Aleksander Iwański; Paweł Górski; Wojciech Jerzy Piotrowski Journal: Chron Respir Dis Date: 2019 Jan-Dec Impact factor: 2.444